Clinical Trials Logo

Colorectal Cancer clinical trials

View clinical trials related to Colorectal Cancer.

Filter by:

NCT ID: NCT04420013 Not yet recruiting - Colorectal Cancer Clinical Trials

Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon

ColIBRI
Start date: September 2020
Phase:
Study type: Observational

The primary objective of the study aims to compare soluble CD154 (CD40L) levels before and after radiofrequency ablation (RFA) in patients with colorectal cancer (CRC) liver metastases. The secondary objectives aims: - to compare soluble CD154 (sCD40-L) levels before and after treatment by RFA or surgery alone in patients with CRC liver metastases; - to study the feasibility and reliability of soluble CD154 (sCD40-L) levels to detect and quantify the induction of immun response in CRC liver metastases patients after RFA; - to study the impact of surgery on plasma soluble CD154 levels; - to study association between CD154 expression level before and after RFA in CRC liver metastases patients and relapses rate at 1 year.

NCT ID: NCT04417010 Not yet recruiting - Colorectal Cancer Clinical Trials

To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation

Start date: June 1, 2020
Phase:
Study type: Observational

To investigate the clinical effect of radiofrequency ablation on colorectal cancer liver metastases with different KRAS gene status

NCT ID: NCT04401124 Not yet recruiting - Colorectal Cancer Clinical Trials

Status of Management of Surgery in Beijing During COVID-19

Start date: May 25, 2020
Phase:
Study type: Observational

This is a multi-centered, retrospective, observational study aimed at observing the current status of the management of gastrointestinal surgery during the COVID-19 pandemic, particularly the changes on surgery protocols and other key aspects of surgical workflow, so as to share experience with colleagues both domestic and abroad.

NCT ID: NCT04343950 Not yet recruiting - Breast Cancer Clinical Trials

SMS Messaging as a Tool to Improve Cancer Screening Programs

M-TICS
Start date: September 15, 2020
Phase: N/A
Study type: Interventional

The aim of this project is to assess the impact on health and economics of the implementation of text messaging (SMS) in cancer screening programs. Three interventions with SMS will be evaluated through community trials. In the colorectal cancer screening program the following interventions will be tested: a) Participation reminder: six weeks after sending the invitation letter of the colorectal cancer program if there has not been a response, a reminder SMS will be sent in front of the usual method by letter; b) Reminder to return the fecal occult blood test: SMS reminder of test delivery versus no intervention. This reminder will be sent to the individuals who have gone to the pharmacy to pick up a fecal occult blood test and they have not returned it after 14 days. The impact on participation will be analyzed and, if applicable, the proportion of advanced neoplasms will be calculated by increase in participation. In the breast cancer screening program, the invitation by SMS versus the usual invitation by letter will be studied in women who had participated in the previous screening round. The impact on participation will be analyzed. A cost-effectiveness analysis of the three interventions will be carried out. The incremental cost ratio of the interventions between cost variation and effectiveness variation will be calculated.

NCT ID: NCT04313764 Not yet recruiting - Colorectal Cancer Clinical Trials

Ultrasound-Guided Erector Spinae Plan Block for Colorectal Surgery

Start date: June 18, 2020
Phase: N/A
Study type: Interventional

Colorectal cancer is a common and lethal disease. It still remains the third most common cause of cancer death in women and the second leading cause of death in men. Pain control is an important direction of postoperative management in malignancy surgery. Inadequate pain control increases cardiac and respiratory complications in these critical patients. Erector spinae plane (ESP) block is a recently described regional anesthesia technique that blocks the dorsal and ventral rami of the spinal nerves and the sympathetic nerve fibers. While the ESP block has been shown to provide effective postoperative analgesia after thoracic, and abdominal surgeries. Our aim in this study was to investigate bilateral thoracic ESP block for providing successful postoperative pain management following colorectal surgery.

NCT ID: NCT04298320 Not yet recruiting - Colorectal Cancer Clinical Trials

A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC(SHR-1210-AIN457)

Start date: March 15, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase Ib/IIa, Open-label, Investigator-initiated Trail of SHR-1210 (an Anti-PD-1 Inhibitor) in combination with AIN457 for patients with late stage MSS CRC who failed second-line and above treatment. The main purpose of this study is to evaluate the safety, tolerability and RD of SHR-1210 combination with AIN457 as a treatment of MSS CRC.

NCT ID: NCT04296630 Not yet recruiting - Colorectal Cancer Clinical Trials

Social Media for Colorectal Cancer Screening

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Using social media for health promotion is an innovative and emerging approach but remains relatively unexplored in cancer screening. Uptake of colorectal cancer (CRC) screening remains low and standard methods of reaching out are expensive with limited impact. The objective of this study is to conduct a cluster randomized controlled trial (RCT) to test the effectiveness of social media messages for CRC screening on screening intention (primary outcome). The results of this trial will be of interest to Cancer Care Ontario and are likely to be taken up by other screening programs looking for innovative and novel ways to increase screening participation. The study results will be easily translatable identifying the most compelling CRC screening messages while the approach can easily be translated to other cancer disease sites with screening programs.

NCT ID: NCT04294953 Not yet recruiting - Colorectal Cancer Clinical Trials

Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery

Start date: March 1, 2020
Phase: Phase 2
Study type: Interventional

Our aim will be to evaluate the efficacy of perioperative Duloxetine in decreasing acute postoperative pain after laparoscopic colorectal cancer surgery and its role in reducing postoperative morphine requirements

NCT ID: NCT04270851 Not yet recruiting - Cancer Clinical Trials

Colorectal Liver Metastases: Novel Assessment Tools for Technical Resectability

CoNoR
Start date: April 2020
Phase:
Study type: Observational

The CoNoR study aims to assess whether the use of the LiMAx test and the HepaT1ca pre-operative planning magnetic resonance scan impact upon technical resectability decision-making in colorectal liver metastases (CLM).

NCT ID: NCT04269746 Not yet recruiting - Colorectal Cancer Clinical Trials

Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients

Start date: December 2020
Phase:
Study type: Observational

1. Evaluate the diagnostic value of long noncoding RNA (CCAT1) expression by RT-PCR in peripheral blood in colorectal cancer patients versus normal healthy control personal. 2. Evaluate the clinical utility of detecting long noncoding RNA (CCAT1) expression in diagnosis of colorectal cancer patients & its relation to tumor staging. 3. Evaluate the clinical utility of detecting long noncoding RNA (CCAT1) expression in precancerous colorectal diseases. 4. Compare long noncoding RNA (CCAT1) expression with traditional marker; carcinoembryonic antigen (CEA) and Carbohydrate antigen 19-9 (CA19-9) in diagnosis of colorectal cancer.